Logo image of ZONE

CLEANCORE SOLUTIONS INC-CL B (ZONE) Stock Fundamental Analysis

NYSEARCA:ZONE - NYSE Arca - US1844921064 - Common Stock - Currency: USD

1.565  -0.05 (-2.8%)

Fundamental Rating

1

ZONE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. ZONE may be in some trouble as it scores bad on both profitability and health. ZONE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ZONE had negative earnings in the past year.
ZONE had a negative operating cash flow in the past year.
ZONE Yearly Net Income VS EBIT VS OCF VS FCFZONE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

Looking at the Return On Assets, with a value of -30.50%, ZONE is doing worse than 86.72% of the companies in the same industry.
Looking at the Return On Equity, with a value of -61.07%, ZONE is doing worse than 82.81% of the companies in the same industry.
Industry RankSector Rank
ROA -30.5%
ROE -61.07%
ROIC N/A
ROA(3y)-49.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZONE Yearly ROA, ROE, ROICZONE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 49.58%, ZONE belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
ZONE's Gross Margin has improved in the last couple of years.
ZONE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.73%
GM growth 5YN/A
ZONE Yearly Profit, Operating, Gross MarginsZONE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

3

2. Health

2.1 Basic Checks

ZONE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZONE has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ZONE has an improved debt to assets ratio.
ZONE Yearly Shares OutstandingZONE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
ZONE Yearly Total Debt VS Total AssetsZONE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

ZONE has an Altman-Z score of 0.45. This is a bad value and indicates that ZONE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ZONE (0.45) is worse than 82.81% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that ZONE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.70, ZONE is doing worse than 67.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z 0.45
ROIC/WACCN/A
WACC11.66%
ZONE Yearly LT Debt VS Equity VS FCFZONE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

A Current Ratio of 2.13 indicates that ZONE has no problem at all paying its short term obligations.
With a Current ratio value of 2.13, ZONE perfoms like the industry average, outperforming 58.59% of the companies in the same industry.
ZONE has a Quick Ratio of 1.69. This is a normal value and indicates that ZONE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.69, ZONE is in the better half of the industry, outperforming 70.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.69
ZONE Yearly Current Assets VS Current LiabilitesZONE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

0

3. Growth

3.1 Past

ZONE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.11%, which is quite impressive.
The Revenue for ZONE has decreased by -34.26% in the past year. This is quite bad
The Revenue has been decreasing by -1.36% on average over the past years.
EPS 1Y (TTM)27.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.2%
Revenue 1Y (TTM)-34.26%
Revenue growth 3Y-1.36%
Revenue growth 5YN/A
Sales Q2Q%51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZONE Yearly Revenue VS EstimatesZONE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

0

4. Valuation

4.1 Price/Earnings Ratio

ZONE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZONE Price Earnings VS Forward Price EarningsZONE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZONE Per share dataZONE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZONE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEANCORE SOLUTIONS INC-CL B

NYSEARCA:ZONE (5/22/2025, 8:04:00 PM)

1.565

-0.05 (-2.8%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.14%
Inst Owner Change21.08%
Ins Owners58.95%
Ins Owner Change1.9%
Market Cap13.26M
AnalystsN/A
Price TargetN/A
Short Float %3.49%
Short Ratio1.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.26
P/FCF N/A
P/OCF N/A
P/B 3.55
P/tB 1132.95
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.19
BVpS0.44
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.5%
ROE -61.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.58%
FCFM N/A
ROA(3y)-49.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.73%
GM growth 5YN/A
F-Score4
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.71%
Cap/Sales 0.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 1.69
Altman-Z 0.45
F-Score4
WACC11.66%
ROIC/WACCN/A
Cap/Depr(3y)62.75%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.26%
Revenue growth 3Y-1.36%
Revenue growth 5YN/A
Sales Q2Q%51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y61.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-338.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-337.14%
OCF growth 3YN/A
OCF growth 5YN/A